Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV vaccine candidates.

Tai Te Wu1, George Johnson

  • 1Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois, USA. t-wu@northwestern.edu

Drugs of Today (Barcelona, Spain : 1998)
|January 13, 2005
PubMed
Summary

Researchers identified conserved segments in the HIV-1 surface protein gp120, proposing them as potential vaccine candidates. These segments may overcome limitations of current HIV vaccines by eliciting broader antibody responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Primary and Immortalized Microglia Exhibit Divergent Responses to Hemoglobin" [Experimental Neurology 403 (2026) 115838].

Experimental neurology·2026
Same author

Primary and immortalized microglia exhibit divergent responses to hemoglobin.

Experimental neurology·2026
Same author

Concurrence of Calcium Pyrophosphate Deposition Disease in Patients Undergoing Surgery for Degenerative Spine Conditions: A Case Series and Systematic Review.

Cureus·2026
Same author

Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Quantitative evaluation of genotoxicity data for risk assessment and regulatory decision-making: Time for a paradigm shift.

Environment international·2026
Same author

Deep learning and object detection methods for scoring cell types within the human buccal cell micronucleus and cytome assays for human biomonitoring.

Mutagenesis·2025

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • HIV-1 surface protein gp120 exhibits significant sequence variability, complicating vaccine design.
  • Current HIV vaccines targeting variable regions like the V3-loop elicit isolate-specific antibodies, lacking broad protection.
  • Vaccines using conserved peptides from other HIV proteins fail to prevent viral entry and integration.

Purpose of the Study:

  • To identify conserved regions within the HIV-1 gp120 protein for potential vaccine development.
  • To analyze aligned amino acid sequences of gp120 to find invariant segments.
  • To propose novel vaccine strategies based on conserved gp120 segments.

Main Methods:

  • Bioinformatic analysis of aligned amino acid sequences of HIV-1 gp120 from Los Alamos National Laboratory.
  • Identification of consecutive, nearly invariant amino acid residue segments (≥7 residues).
  • Evaluation of the spatial proximity and disulfide bonding of identified segments in gp120 structure.

Main Results:

  • Discovery of several conserved segments (≥7 amino acids) in the C1, C2, and C5 regions of gp120.
  • Four conserved segments are spatially close in the known 3D structure of the gp120 core.
  • Two additional conserved segments are linked by disulfide bonds.

Conclusions:

  • The identified conserved segments in gp120 are proposed as a basis for novel HIV vaccine candidates.
  • Combining these segments could lead to vaccines eliciting broader antibody responses.
  • Further research should incorporate processed peptides and investigate the impact of variable loops on antibody production over time.

Related Experiment Videos